Latest metastatic breast cancer Stories
Median progression-free survival of 7.6 months reported for overall study population whose disease has progressed on a median of 4 prior therapies CAMBRIDGE, Mass., April 20, 2015 /PRNewswire/
GUILDFORD, England, April 20, 2015 /PRNewswire/ -- ANGLE plc (AIM:AGL OTCQX:ANPCY), the specialist medtech company, is pleased to announce that the Sidney Kimmel Cancer Center at Thomas Jefferson
RnRMarketResearch.com adds HER-2 Positive Breast Cancer Market in the US 2015-2019 and Global HER-2 Positive Breast Cancer Market 2015-2019 industry research reports in its store. DALLAS, March
--- Significant Survival Benefit Observed in Pre-Specified Subgroups Including Patients with Brain Metastases and Patients with Baseline Liver Metastases --- SAN FRANCISCO, March
Eisai Demonstrates Commitment to Patients with Rare Cancers WOODCLIFF LAKE, N.J., Feb. 25, 2015 /PRNewswire/ -- Eisai Inc.
Training program for women with metastatic breast cancer seeks applicants HAVERFORD, Pa., Feb.
One of the nation’s leading specialty pharmacies, BioPlus, will dispense Ibrance (palbociclib) and services for this advanced breast cancer medication. Altamonte
FLINT, Mich., Feb. 4, 2015 /PRNewswire/ -- Diplomat Pharmacy, Inc.
Grants Focus on Enhancing Patient Support and Efforts to Increase Public Understanding of the Disease NEW YORK, Jan. 21, 2015 /PRNewswire-USNewswire/ -- Today, Pfizer Inc.
- A serpent whose bite was fabled to produce intense thirst.